Log in

FSD Pharma Stock Price, Forecast & Analysis (OTCMKTS:FSDDF)

0.00 (0.00 %)
(As of 10/18/2019)
Today's Range
Now: $4.97
50-Day Range
MA: $2.94
52-Week Range
Now: $4.97
Volume6,084 shs
Average Volume319,337 shs
Market Capitalization$6.90 billion
P/E RatioN/A
Dividend YieldN/A
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of the indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for various central nervous system disorders, including chronic pain, fibromyalgia, and irritable bowel syndrome. It has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products. FSD Pharma Inc. is headquartered in Cobourg, Canada.

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual SalesN/A



Outstanding Shares1,388,450,000
Market Cap$6.90 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive FSDDF News and Ratings via Email

Sign-up to receive the latest news and ratings for FSDDF and its competitors with MarketBeat's FREE daily newsletter.

FSD Pharma (OTCMKTS:FSDDF) Frequently Asked Questions

What is FSD Pharma's stock symbol?

FSD Pharma trades on the OTCMKTS under the ticker symbol "FSDDF."

Has FSD Pharma been receiving favorable news coverage?

Media stories about FSDDF stock have trended somewhat negative recently, InfoTrie Sentiment reports. The research firm scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. FSD Pharma earned a coverage optimism score of -1.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for FSD Pharma.

Who are some of FSD Pharma's key competitors?

What other stocks do shareholders of FSD Pharma own?

Who are FSD Pharma's key executives?

FSD Pharma's management team includes the folowing people:
  • Mr. Anthony John Durkacz, Founder & Co-Chairman (Age 43)
  • Dr. Raza Bokhari M.B.A., MBA, Exec. Co-Chairman & Interim CEO (Age 51)
  • Mr. Zeeshan Saeed, Founder, Pres & Director
  • Mr. Donal Carroll, Interim CFO
  • Dr. Sara May, Pres of FV Pharma

How do I buy shares of FSD Pharma?

Shares of FSDDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is FSD Pharma's stock price today?

One share of FSDDF stock can currently be purchased for approximately $4.97.

How big of a company is FSD Pharma?

FSD Pharma has a market capitalization of $6.90 billion. View Additional Information About FSD Pharma.

MarketBeat Community Rating for FSD Pharma (OTCMKTS FSDDF)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  33 (Vote Outperform)
Underperform Votes:  16 (Vote Underperform)
Total Votes:  49
MarketBeat's community ratings are surveys of what our community members think about FSD Pharma and other stocks. Vote "Outperform" if you believe FSDDF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FSDDF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel